A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China-Reference-Cited by-同舟云学术

A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China

Published:2008-08 Issue:35 Volume:26 Page:4608-4616
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Zhuang Gui-Hua,Pan Xin-Juan,Wang Xue-Liang

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference43 articles.

1. World Health Organization. Hepatitis A vaccines: WHO position paper. Weekly Epidemiological Record 2000;75(5):38–42. Available at URL: http://www.who.int/wer/pdf/2000/wer7505.pdf.

2. Frequency of illness associated with epidemic hepatitis A virus infections in adults;Lednar;Am J Epidemiol,1985

3. Type A viral hepatitis: epidemiology, diagnosis, and prevention;Lemon;Clin Chem,1997

4. HAV infection in chronic liver disease: a rationale for vaccination;Almasio;Vaccine,2003

5. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns;Jacobsen;Int J Epidemiol,2005

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effective analysis of hepatitis A vaccination in Kerala state, India;PLOS ONE;2024-06-27

2. Health policy, price regulation, and innovation: Evidence from China’s vaccine industry;Journal of Development Economics;2024-03

3. Health Policy, Innovation, and Soes: Evidence from China's Vaccine Industry;SSRN Electronic Journal;2022

4. Quality of Health Economic Evaluations in Mainland China: A Comparison of Peer-Reviewed Articles in Chinese and in English;Applied Health Economics and Health Policy;2021-07-29

5. Hepatitis a virus infection in Central-West Tunisia: an age structured model of transmission and vaccination impact;BMC Infectious Diseases;2020-08-26